These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 7946163)
1. Electrolyte changes and metabolic effects of lisinopril/bendrofluazide treatment. Results from a randomized, double-blind study with parallel groups. Haenni A; Andersson PE; Lind L; Berne C; Lithell H Am J Hypertens; 1994 Jul; 7(7 Pt 1):615-22. PubMed ID: 7946163 [TBL] [Abstract][Full Text] [Related]
2. Skeletal muscle magnesium content is correlated with plasma glucose concentration in patients with essential hypertension treated with lisinopril or bendrofluazide. Haenni A; Reneland R; Andersson PE; Lind L; Lithell H Am J Hypertens; 2002 Aug; 15(8):735-8. PubMed ID: 12160198 [TBL] [Abstract][Full Text] [Related]
3. Effects of low dose versus conventional dose thiazide diuretic on insulin action in essential hypertension. Harper R; Ennis CN; Sheridan B; Atkinson AB; Johnston GD; Bell PM BMJ; 1994 Jul; 309(6949):226-30. PubMed ID: 7818648 [TBL] [Abstract][Full Text] [Related]
4. The blood pressure response to antihypertensive treatment with lisinopril or bendrofluazide is related to the calcium and magnesium contents in skeletal muscle. Haenni A; Lind L; Lithell H Am J Hypertens; 1996 Mar; 9(3):273-6. PubMed ID: 8695028 [TBL] [Abstract][Full Text] [Related]
5. Comparison of enalapril and bendrofluazide for treatment of systemic hypertension. Zezulka AV; Gill JS; Dews I; Joy MD; Beevers DG Am J Cardiol; 1987 Mar; 59(6):630-3. PubMed ID: 3030087 [TBL] [Abstract][Full Text] [Related]
6. Verapamil and bendrofluazide in the treatment of hypertension: a controlled study of effectiveness alone and in combination. Benjamin N; Phillips RJ; Robinson BF Eur J Clin Pharmacol; 1988; 34(3):249-53. PubMed ID: 3294021 [TBL] [Abstract][Full Text] [Related]
7. A comparison of the effects of low- and conventional-dose thiazide diuretic on insulin action in hypertensive patients with NIDDM. Harper R; Ennis CN; Heaney AP; Sheridan B; Gormley M; Atkinson AB; Johnston GD; Bell PM Diabetologia; 1995 Jul; 38(7):853-9. PubMed ID: 7556989 [TBL] [Abstract][Full Text] [Related]
8. A comparison of the acute effects of cicletanine and bendrofluazide on urinary electrolytes and plasma potassium in essential hypertension. Singer DR; Markandu ND; Sugden AL; MacGregor GA Eur J Clin Pharmacol; 1990; 39(3):227-32. PubMed ID: 2257857 [TBL] [Abstract][Full Text] [Related]
10. Lisinopril is neutral to insulin sensitivity and serum lipoproteins in essential hypertensive patients. Thürig C; Böhlen L; Schneider M; de Courten M; Shaw SG; Riesen W; Weidmann P Eur J Clin Pharmacol; 1995; 49(1-2):21-6. PubMed ID: 8751016 [TBL] [Abstract][Full Text] [Related]
11. A comparative study of long acting diltiazem (Tildiem LA) with sustained release nifedipine (nifedipine SR) and bendrofluazide in the treatment of mild to moderate hypertension. Hosie J; Nasar MA; Belgrave GP; Walters EG Acta Cardiol; 1994; 49(3):251-65. PubMed ID: 7941918 [TBL] [Abstract][Full Text] [Related]
12. Serum aldosterone changes during hyperinsulinemia are correlated to body mass index and insulin sensitivity in patients with essential hypertension. Haenni A; Reneland R; Lind L; Lithell H J Hypertens; 2001 Jan; 19(1):107-12. PubMed ID: 11204289 [TBL] [Abstract][Full Text] [Related]
13. Association between serum lipids, glucose tolerance, and insulin sensitivity during 12 months of celiprolol treatment. Malminiemi K Cardiovasc Drugs Ther; 1995 Apr; 9(2):295-304. PubMed ID: 7662596 [TBL] [Abstract][Full Text] [Related]
14. Effect of chronic treatment with lacidipine or lisinopril on intracellular partitioning of glucose metabolism in type 2 diabetes mellitus. Bonora E; Targher G; Alberiche M; Bonadonna RC; Saggiani F; Zenere MB; Uleri S; Muggeo M J Clin Endocrinol Metab; 1999 May; 84(5):1544-50. PubMed ID: 10323377 [TBL] [Abstract][Full Text] [Related]
15. Doxazosin versus bendrofluazide: a comparison of the metabolic effects in British South Asians with hypertension. Hobbs FR; Khan T; Collins B Br J Gen Pract; 2005 Jun; 55(515):437-43. PubMed ID: 15970067 [TBL] [Abstract][Full Text] [Related]
16. Indapamide and bendrofluazide: a comparison in the management of essential hypertension. Bing RF; Russell GI; Swales JD; Thurston H Br J Clin Pharmacol; 1981 Dec; 12(6):883-6. PubMed ID: 7041937 [TBL] [Abstract][Full Text] [Related]
17. Effect of angiotensin converting enzyme inhibitor (lisinopril) on insulin sensitivity and sodium transport in mild hypertension. Falkner B; Canessa M; Anzalone D Am J Hypertens; 1995 May; 8(5 Pt 1):454-60. PubMed ID: 7662220 [TBL] [Abstract][Full Text] [Related]
18. Contribution of atenolol, bendrofluazide, and hydrallazine to management of severe hypertension. Wilcox RG; Mitchell JR Br Med J; 1977 Aug; 2(6086):547-50. PubMed ID: 329948 [TBL] [Abstract][Full Text] [Related]
19. Treatment of hypertension with a fixed ratio combination of long-acting propranolol and bendrofluazide, and influence of age of the subject. Herrick AL; Davis JM; Weir RJ Br J Clin Pract; 1989 Jun; 43(6):196-200. PubMed ID: 2597598 [TBL] [Abstract][Full Text] [Related]
20. Effects of celiprolol on insulin sensitivity and glucose tolerance in dyslipidemic hypertension. Malminiemi K; Lahtela JT; Huupponen R Int J Clin Pharmacol Ther; 1995 Mar; 33(3):156-63. PubMed ID: 7599914 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]